INIS
patients
100%
biopsy
83%
liquids
75%
organoids
75%
budgets
75%
glioblastomas
75%
colon
75%
castration
75%
tumors
49%
stem cells
24%
tissues
24%
cancer
20%
therapy
20%
organs
16%
drugs
16%
biological markers
12%
nucleosomes
12%
tumor cells
12%
brain
12%
dna
12%
reviews
12%
blood
12%
origin
8%
microscopy
8%
surgery
8%
cost
8%
tools
8%
offsprings
8%
laboratories
8%
cell cultures
8%
resolution
8%
range
8%
adults
8%
comparative evaluations
8%
Keyphrases
Patient-derived
75%
Budget-friendly
75%
Colonoids
75%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
75%
Liquid Biopsy
75%
Patient-derived Organoids
37%
Phenotypic Heterogeneity
18%
Two-dimensional Cell Culture
18%
Targeted Drug Therapy
18%
Personalized Therapy
18%
Primary Tissue
18%
Organoid Models
18%
Super-resolution Microscopy
18%
Febrile Neutropenia
16%
Hand-foot Syndrome
16%
Circulating nucleosomes
15%
Circulating Tumor Cells
15%
Circulating Biomarkers
15%
Glioma Diagnosis
15%
Circulating Tumor DNA (ctDNA)
15%
Prostate-specific Antigen Response
8%
Weekly Docetaxel
8%
Recommended Phase 2 Dose
8%
Dose-escalation Study
8%
Neutropenia
8%
Medicine and Dentistry
Organoid
75%
Colon
75%
Biochemical Analysis
75%
Liquid Biopsy
75%
Neoplasm
24%
Brain Tumor
12%
Nucleosome
12%
Circulating Tumor Cell
12%
Circulating Tumor DNA
12%
Colorectal Cancer
8%
Pluripotent Stem Cell
8%
Child
8%
Health Care Cost
8%
Embryonic Stem Cell
8%
Personalized Medicine
8%
Drug Therapy
8%
Translational Research
8%
Drug Response
8%
Biopsy
8%
Adult Stem Cell
8%
Surgery
8%
Immunoblotting
8%
Cell Culture
8%